Change in peripheral blood malignant lymphocyte count after 7 days of thalidomide treatment
Patient no. . | ALC at baseline, × 109 cells/L . | ALC on day 7, × 109 cells/L . | % change . |
---|---|---|---|
1 | 106.85 | 114.30 | +7 |
2 | 201.30 | 210.74 | +5 |
3 | 73.50 | 69.70 | -5 |
4 | 1.94 | 1.70 | -12 |
5 | 11.00 | 8.31 | -24 |
6 | 39.19 | 28.78 | -27 |
7 | 110.90 | 67.70 | -39 |
8 | 44.34 | 20.10 | -55 |
9 | 123.30 | 55.80 | -55 |
10 | 41.20 | 18.64 | -55 |
11 | 115.20 | 49.60 | -57 |
12 | 33.08 | 12.69 | -62 |
13 | 6.71 | 1.07 | -84 |
Patient no. . | ALC at baseline, × 109 cells/L . | ALC on day 7, × 109 cells/L . | % change . |
---|---|---|---|
1 | 106.85 | 114.30 | +7 |
2 | 201.30 | 210.74 | +5 |
3 | 73.50 | 69.70 | -5 |
4 | 1.94 | 1.70 | -12 |
5 | 11.00 | 8.31 | -24 |
6 | 39.19 | 28.78 | -27 |
7 | 110.90 | 67.70 | -39 |
8 | 44.34 | 20.10 | -55 |
9 | 123.30 | 55.80 | -55 |
10 | 41.20 | 18.64 | -55 |
11 | 115.20 | 49.60 | -57 |
12 | 33.08 | 12.69 | -62 |
13 | 6.71 | 1.07 | -84 |